Weekly Intelligence Brief · For Healthtech Compliance Teams

30+ regulatory sources.
One Monday morning email.

AI regulation in healthcare — what moved, what it means, what to do about it.

Every Monday, you open your inbox wondering what changed. FDA guidance, 45 states legislating AI independently, HIPAA enforcement actions, EU AI Act deadlines — and the federal government actively contesting the state laws you're trying to comply with. Your team can't track it all. Outside counsel charges $500/hr to tell you what you missed.

The Compliance Signal monitors 30+ regulatory sources daily and delivers what matters every Monday morning. 5 sections. 8 minutes. Action items your team can execute this week.

Free sample issue delivered immediately. No credit card required.

Get the free sample issue

Delivered to your inbox in 60 seconds. No credit card required.

Compliance intelligence, not compliance noise

Every section ends with what to do. Not "consider evaluating" — actual steps your team can execute this week.

Weekly Digest

Every Monday: the 4–5 regulatory developments that actually affect your product. Analyzed, sourced, and translated into action items.

Breaking Alerts

When the FDA drops surprise guidance or a state signs a new AI law mid-week, you know the same day — not when your lawyer bills you to find out.

Multi-Jurisdiction

FDA, HIPAA/HITECH, California, Colorado, Texas, Illinois, EU AI Act, UK MHRA — one brief covers every regulatory surface your product touches.

Source-Linked Analysis

Every claim sourced. Every interpretation flagged. You get the primary documents and our read on them — so your legal team can verify in minutes, not hours.

From 30+ sources to your inbox in three steps

1
We Monitor

30+ regulatory sources scanned daily — FDA, HIPAA enforcement actions, state legislatures, EU AI Act developments, and 12+ law firm advisories.

2
We Analyze

AI identifies what matters to healthtech. A human editor with compliance background verifies accuracy, adds interpretation, and writes the action items.

3
You Act

Monday morning, your inbox has the 4–5 developments that affect your product — with specific steps your team can execute this week. 8 minutes, done.

Don't take our word for it. Read one.

One full section from this week's issue — sourcing, analysis, and action items included.

The Compliance Signal
Issue #003
5 sections · 8 min read · 5 action items
This Week
01FDA rewrote the cybersecurity rules for your medical device. SBOMs are now mandatory.
02Your QMS just changed. QMSR is live and FDA has new inspection powers.
03HHS wants to rewrite the HIPAA Security Rule. Here's what that means for AI.
04Three healthcare orgs hit by ransomware in one week. The pattern is the point.
05FDA warns 30 telehealth companies. The enforcement pattern just got bigger.

FDA rewrote the cybersecurity rules for your medical device. If you submit without an SBOM, they won't even open the application.

FDA Cybersecurity Action Required

On February 3, FDA published the revised final guidance "Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions." Fact This is the third iteration since September 2023, updated specifically to align with the QMSR transition (see Section 02).

Why it matters: This guidance has statutory teeth. Section 524B of the FD&C Act — added by the Consolidated Appropriations Act of 2023 — makes cybersecurity requirements legally enforceable for any "cyber device": a device that includes software, can connect to the internet, and has characteristics making it vulnerable to cyberthreats. Fact

That definition covers every AI-enabled medical device, every SaMD product, and most connected diagnostics on the market. Our Read

The SBOM requirement is the headline. Under Section 524B(b)(3), every cyber device submission must include a machine-readable Software Bill of Materials in SPDX or CycloneDX format. This is not a recommendation — it is a legal requirement. Fact

FDA has signaled that incomplete SBOM submissions will be placed on hold, which in practice means your application won't advance until cybersecurity documentation is complete. Signal

Action Items
  • Audit your current premarket submission pipeline for SBOM inclusion in SPDX or CycloneDX format
  • Confirm your software engineering team can generate machine-readable SBOMs for every component, including third-party libraries
  • Review your TPLC cybersecurity plan against the updated guidance before your next 510(k) or De Novo submission

That's one section. Subscribers get five every Monday.

How to read this: Fact Verified, sourced Signal Directional, evidence-based Our Read Flagged interpretation
"The volume and pace of change is crazy these days."

— 20-year compliance veteran, HFMA 2025

Subscribe free. Sample issue in your inbox in 60 seconds.

30+ sources monitored daily. 8 minutes every Monday. No credit card required.

30+ regulatory sources. One brief.

We read the Federal Register, OCR enforcement actions, and state legislature trackers so you can read an 8-minute email.

FDA HHS CMS ONC / ASTP FTC Federal Register OCR / HIPAA California Colorado Texas Illinois New York EU AI Act EU MDR UK MHRA IAPP NCSL Tracker 12+ Law Firms

Including Wilson Sonsini, White & Case, King & Spalding, Orrick, Manatt Health, Faegre Drinker, and more.

You might recognize this

92.6% of compliance professionals say the role has gotten harder. If you're one of them, you already know.

"The volume and pace of change is crazy these days" — that's a 20-year compliance veteran, not us. You check FDA.gov on your lunch break because nobody else will.
You maintain the spreadsheet nobody else looks at — regulatory deadlines across jurisdictions. It's always three weeks out of date.
Your team is 2–5 people. Your scope covers every jurisdiction your product touches. The HCCA benchmark confirms you're not alone — nearly half of compliance teams at mid-market organizations are the same size.
You want to build compliance programs, not scan for threats. Policies, vendor assessments, governance frameworks — that's the work. Instead, you're the scanning function and the compliance team in one seat.

If you build healthtech that touches AI and patient data, this was written specifically for you.

AI-researched. Human QA'd. Fully transparent.

We don't pretend to be a team of lawyers. The Compliance Signal is researched and drafted by AI systems purpose-built to monitor 30+ regulatory sources daily. Every issue is reviewed and approved by a human editor before it reaches your inbox.

But you don't have to trust the process — you can verify the output. Every factual claim links directly to the primary source: the Federal Register entry, the FDA guidance document, the state statute. Your legal team can confirm any claim in minutes.

Every statement is marked as one of three types: Fact (verified, sourced), Signal (regulatory direction with observable evidence), or Our Read (our interpretation, flagged explicitly). You always know which is which.

When we get something wrong, we correct it in the next issue — openly, not silently. Accuracy over speed. Honesty over polish.

Already reading? Upgrade to never miss an issue.

The free issue shows you what we cover. A paid subscription means you never miss a week.

Monthly
Annual Save $300
$100/mo
$150/mo after your first month
  • Every Monday. 8 minutes. Every jurisdiction.
  • Source-linked — your legal team verifies in minutes.
  • Breaking alerts same-day.
  • Searchable archive of every past issue.
  • Action items your team can execute this week.
  • One subscription covers your whole team. Forward to anyone at your company.
Upgrade to Paid
Cancel anytime. No contracts.

Before you decide

Is this legal advice?

No. The Compliance Signal is regulatory intelligence — not legal counsel. We monitor, analyze, and translate regulatory developments into action items. Your legal team makes the decisions. We make sure they have the information to make them well.

How is this different from just reading the Federal Register?

The Federal Register is one source with no interpretation. We cover 30+ sources across FDA, HIPAA enforcement, state legislatures, the EU AI Act, and 12+ law firm advisories — and we tell you what it means for your product and what to do about it.

Is this written by AI?

Researched and drafted by purpose-built AI systems. Reviewed and approved by a human editor before every issue ships. Every claim is classified as verified fact, directional signal, or flagged interpretation — so you always know what you're reading.

What if nothing significant happens in a given week?

We tell you that. You're paying for signal, not filler. A quiet week is a useful data point — it means your team can focus on execution instead of scanning for threats.

Can I cancel anytime?

Yes. Monthly subscription, cancel with one click. No contracts, no cancellation fees, no questions.

What jurisdictions do you cover?

Federal — FDA, HHS, CMS, ONC, FTC, OCR/HIPAA, Federal Register. State — California, Colorado, Texas, Illinois, New York, and any state that introduces AI healthcare legislation. International — EU AI Act, EU MDR, UK MHRA. When a new jurisdiction passes relevant regulation, we add it.

Not ready to pay? Start with the free issue.

See what 30+ sources distilled into 8 minutes looks like.

Delivered to your inbox in 60 seconds. No credit card required.